These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 33590951)
1. Sulforaphane suppresses lipopolysaccharide- and Pam3CysSerLys4-mediated inflammation in chronic obstructive pulmonary disease via toll-like receptors. Zeng X; Liu X; Bao H FEBS Open Bio; 2021 May; 11(5):1313-1321. PubMed ID: 33590951 [TBL] [Abstract][Full Text] [Related]
2. [Effects of sulforaphane on Toll-like receptor 4/myeloid differentiation factor 88 pathway of monocyte-derived macrophages from patients with chronic obstructive pulmonary disease]. Zeng X; Liu X; Bao H; Zhang Y; Wang X; Shi K; Pang Q Zhonghua Jie He He Hu Xi Za Zhi; 2014 Apr; 37(4):250-4. PubMed ID: 24969711 [TBL] [Abstract][Full Text] [Related]
3. Effects of budesonide on toll-like receptor expression in alveolar macrophages from smokers with and without COPD. Ji J; von Schéele I; Billing B; Dahlén B; Lantz AS; Larsson K; Palmberg L Int J Chron Obstruct Pulmon Dis; 2016; 11():1035-43. PubMed ID: 27274225 [TBL] [Abstract][Full Text] [Related]
4. The effects of repeated Toll-like receptors 2 and 4 stimulation in COPD alveolar macrophages. Lea SR; Reynolds SL; Kaur M; Simpson KD; Hall SR; Hessel EM; Singh D Int J Chron Obstruct Pulmon Dis; 2018; 13():771-780. PubMed ID: 29535517 [TBL] [Abstract][Full Text] [Related]
5. Comparing the protective effects of resveratrol, curcumin and sulforaphane against LPS/IFN-γ-mediated inflammation in doxorubicin-treated macrophages. Saleh HA; Ramdan E; Elmazar MM; Azzazy HME; Abdelnaser A Sci Rep; 2021 Jan; 11(1):545. PubMed ID: 33436962 [TBL] [Abstract][Full Text] [Related]
6. Sulforaphane suppresses oligomerization of TLR4 in a thiol-dependent manner. Youn HS; Kim YS; Park ZY; Kim SY; Choi NY; Joung SM; Seo JA; Lim KM; Kwak MK; Hwang DH; Lee JY J Immunol; 2010 Jan; 184(1):411-9. PubMed ID: 19949083 [TBL] [Abstract][Full Text] [Related]
7. IL-37 suppresses MyD88-mediated inflammatory responses in human aortic valve interstitial cells. Zhan Q; Zeng Q; Song R; Zhai Y; Xu D; Fullerton DA; Dinarello CA; Meng X Mol Med; 2017 May; 23():83-91. PubMed ID: 28362018 [TBL] [Abstract][Full Text] [Related]
11. Activation of Toll-like receptors by Burkholderia pseudomallei. West TE; Ernst RK; Jansson-Hutson MJ; Skerrett SJ BMC Immunol; 2008 Aug; 9():46. PubMed ID: 18691413 [TBL] [Abstract][Full Text] [Related]
12. PAFR activation of NF-κB p65 or p105 precursor dictates pro- and anti-inflammatory responses during TLR activation in murine macrophages. Ishizuka EK; Filgueiras LR; Rios FJ; Serezani CH; Jancar S Sci Rep; 2016 Aug; 6():32092. PubMed ID: 27554194 [TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory effect of sulforaphane on LPS-stimulated RAW 264.7 cells and ob/ob mice. Ranaweera SS; Dissanayake CY; Natraj P; Lee YJ; Han CH J Vet Sci; 2020 Nov; 21(6):e91. PubMed ID: 33263238 [TBL] [Abstract][Full Text] [Related]
14. Acylation determines the toll-like receptor (TLR)-dependent positive versus TLR2-, mannose receptor-, and SIGNR1-independent negative regulation of pro-inflammatory cytokines by mycobacterial lipomannan. Doz E; Rose S; Nigou J; Gilleron M; Puzo G; Erard F; Ryffel B; Quesniaux VF J Biol Chem; 2007 Sep; 282(36):26014-25. PubMed ID: 17617634 [TBL] [Abstract][Full Text] [Related]
15. BabaoDan cures hepatic encephalopathy by decreasing ammonia levels and alleviating inflammation in rats. Lu L; Wu C; Lu BJ; Xie D; Wang Z; Bahaji Azami NL; An YT; Wang HJ; Ye G; Sun MY J Ethnopharmacol; 2020 Mar; 249():112301. PubMed ID: 31622746 [TBL] [Abstract][Full Text] [Related]
16. LPS-induced expression of CD14 in the TRIF pathway is epigenetically regulated by sulforaphane in porcine pulmonary alveolar macrophages. Yang Q; Pröll MJ; Salilew-Wondim D; Zhang R; Tesfaye D; Fan H; Cinar MU; Große-Brinkhaus C; Tholen E; Islam MA; Hölker M; Schellander K; Uddin MJ; Neuhoff C Innate Immun; 2016 Nov; 22(8):682-695. PubMed ID: 27688705 [TBL] [Abstract][Full Text] [Related]
17. Protective effect of gedunin on TLR-mediated inflammation by modulation of inflammasome activation and cytokine production: Evidence of a multitarget compound. Borges PV; Moret KH; Raghavendra NM; Maramaldo Costa TE; Monteiro AP; Carneiro AB; Pacheco P; Temerozo JR; Bou-Habib DC; das Graças Henriques M; Penido C Pharmacol Res; 2017 Jan; 115():65-77. PubMed ID: 27641928 [TBL] [Abstract][Full Text] [Related]
18. Characterization of TLR-induced inflammatory responses in COPD and control lung tissue explants. Pomerenke A; Lea SR; Herrick S; Lindsay MA; Singh D Int J Chron Obstruct Pulmon Dis; 2016; 11():2409-2417. PubMed ID: 27729782 [TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 4 and Toll-IL-1 receptor domain-containing adapter protein (TIRAP)/myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages. Schilling D; Thomas K; Nixdorff K; Vogel SN; Fenton MJ J Immunol; 2002 Nov; 169(10):5874-80. PubMed ID: 12421970 [TBL] [Abstract][Full Text] [Related]
20. Regulation of pattern recognition receptors by the apolipoprotein A-I mimetic peptide 4F. White CR; Smythies LE; Crossman DK; Palgunachari MN; Anantharamaiah GM; Datta G Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2631-9. PubMed ID: 22982462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]